CoChat

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index; 8 of the 68 sources its claims cite were checked for support.

Efficacy, cost-utility and physiological effects of Acceptance and Commitment Therapy (ACT) and Behavioural Activation Treatment for Depression (BATD) in patients with chronic low back pain and depression: study protocol of a randomised, controlled trial including mobile-technology-based ecological momentary assessment (IMPACT study)

Open access
Sanabria-Mazo, Juan P, Forero, Carlos G, Cristobal-Narváez, Paula, Suso-Ribera, Carlos, García-Palacios, Azucena, Colomer-Carbonell, Ariadna, Pérez-Aranda, Adrián, Andrés-Rodríguez, Laura, McCracken, Lance M, D'Amico, Francesco, Estivill-Rodríguez, Pere, Carreras-Marcos, Bernat, Montes-Pérez, Antonio, Comps-Vicente, Olga, Esteve, Montserrat, Grasa, Mar, Rosa, Araceli, Cuesta-Vargas, Antonio I, Maes, Michael, Borràs, Xavier, Edo, Silvia, Sanz, Antoni, Feliu-Soler, Albert, Castaño-Asins, Juan R, Luciano, Juan V · 2020 · BMJ Open

Abstract

Introduction: The IMPACT study focuses on chronic low back pain (CLBP) and depression symptoms, a prevalent and complex problem that represents a challenge for health professionals. Acceptance and Commitment Therapy (ACT) and Brief Behavioural Activation Treatment for Depression (BATD) are effective treatments for patients with persistent pain and depression, respectively. The objectives of this 12 month, multicentre, randomised, controlled trial (RCT) are (i) to examine the efficacy and cost-utility of adding a group-based form of ACT or BATD to treatment-as-usual (TAU) for patients with CLBP and moderate to severe levels of depressive symptoms; (ii) identify pre–post differences in levels of some physiological variables and (iii) analyse the role of polymorphisms in the FKBP5 gene, psychological process measures and physiological variables as mediators or moderators of long-term clinical changes. Methods and analysis: Participants will be 225 patients with CLBP and moderate to severe depression symptoms recruited at Parc Sanitari Sant Joan de Déu (St. Boi de Llobregat, Spain) and Hospital del Mar (Barcelona, Spain), randomly allocated to one of the three study arms: TAU vs TAU+ACT versus TAU+BATD. A comprehensive assessment to collect clinical variables and costs will be conducted pretreatment, post-treatment and at 12 months follow-up, being pain interference the primary outcome measure. The following physiological variables will be considered at pretreatment and post-treatment assessments in 50% of the sample: immune-inflammatory markers, hair cortisol and cortisone, serum cortisol, corticosteroid-binding globulin and vitamin D. Polymorphisms in the FKBP5 gene (rs3800373, rs9296158, rs1360780, rs9470080 and rs4713916) will be analysed at baseline assessment. Moreover, we will include mobile-technology-based ecological momentary assessment, through the Pain Monitor app, to track ongoing clinical status during ACT and BATD treatments. Linear mixed-effects models using restricted maximum likelihood, and a full economic evaluation applying bootstrapping techniques, acceptability curves and sensitivity analyses will be computed. Ethics and dissemination: This study has been approved by the Ethics Committee of the Fundació Sant Joan de Déu and Hospital del Mar. The results will be actively disseminated through peer-reviewed journals, conference presentations, social media and various community engagement activities. Trial registration number: NCT04140838

Overview

CoChat Summary

## TL;DR

This is a study protocol for a 12-month multicentre randomized controlled trial testing whether adding group-based ACT or BATD to treatment-as-usual improves outcomes for patients with chronic low back pain and moderate-to-severe depressive symptoms. It also plans cost-utility, physiological, genetic, and ecological momentary assessment analyses, but it reports no results because the trial is a protocol.

## Key findings

  • The planned sample is 225 patients with chronic low back pain and moderate to severe depression, randomized to TAU, TAU+ACT, or TAU+BATD; the study uses pain interference as the primary outcome.
  • The trial will assess clinical outcomes at pretreatment, post-treatment, and 12-month follow-up, and will analyze physiological variables in 50% of the sample.
  • The biomarkers substudy includes immune-inflammatory markers, hair cortisol and cortisone, serum cortisol, corticosteroid-binding globulin, and vitamin D, and will genotype 5 FKBP5 SNPs: rs3800373, rs9296158, rs1360780, rs9470080, rs4713916.
  • The protocol includes smartphone-based EMA via the Pain Monitor app, with twice-daily assessments during the 8-week treatment period; the paper notes that daily compliance in prior work has been as high as 75%.

## Methods

  • Design: 12-month, multicentre, three-arm randomized controlled trial following SPIRIT/CONSORT and health-economic reporting standards; group interventions are 8 weekly 1.5-hour sessions.
  • Sample/data: 225 adults aged 18–70 with CLBP (>3 months), pain intensity >4/10, and PHQ-9 ≥10; recruited from Parc Sanitari Sant Joan de Déu and Hospital del Mar in Spain.
  • Analysis: Intention-to-treat and per-protocol analyses using linear mixed-effects models (restricted maximum likelihood), mediation/path analyses for process variables and outcomes, and cost-utility analyses with bootstrapping, acceptability curves, sensitivity analyses, and 1000 replications for ICUR uncertainty.

## Limitations

  • The paper explicitly states that blinding of patients and therapists will not be possible.
  • The authors state there may be a higher than expected dropout rate because the study lasts 1 year.
  • The authors note that not all recruited patients may have a smartphone or may have unsatisfactory EMA completion rates, so EMA may not be feasible or effective for all participants.
  • Evident from the protocol: because this is a study protocol, the paper provides planned methods only and no outcome data or effect estimates.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2020-038107

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Flowchart of the IMPACT study based on the Consolidated Standards of Reporting Trials guidelines. ACT, Acceptance and Commitment Therapy; BATD, Brief Behavioural Activation Treatment for Depression; CLBP, chronic low back pain; EMA, ecological momentary assessment; ITT, intention-to-treat; TAU, treatment as usual.
Figure 1 Flowchart of the IMPACT study based on the Consolidated Standards of Reporting Trials guidelines. ACT, Acceptance and Commitment Therapy; BATD, Brief Behavioural Activation Treatment for Depression; CLBP, chronic low back pain; EMA, ecological momentary assessment; ITT, intention-to-treat; TAU, treatment as usual.CC BY-NC · PubMed Central

Verification

Claims the paper makes

5 Valid · 0 Not valid · 40 Not checked · 27 Own results and interpretations

12 more claims

Create a free account to see all 72 claims and to verify the 60 references still open.

See all claims — free account
  • It may state two separate claims as one. 14
  • Probably not a substantial claim. 49

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 76 references

Research works printed but not linked: 1

  1. Vázquez-Barquero, 1997, Spanish version of the CSRI: a mental health cost evaluation interview, Arch Neurobiol, 60, 171

Cited by

See all 16

Metadata

Authors
Sanabria-Mazo, J. P., Forero, C. G., Cristobal-Narváez, P., Suso-Ribera, C., García-Palacios, A., Colomer-Carbonell, A., Pérez-Aranda, A., Andrés-Rodríguez, L., McCracken, L. M., D'Amico, F., Estivill-Rodríguez, P., Carreras-Marcos, B., Montes-Pérez, A., Comps-Vicente, O., Esteve, M., Grasa, M., Rosa, A., Cuesta-Vargas, A. I., Maes, M., Borràs, X., Edo, S., Sanz, A., Feliu-Soler, A., Castaño-Asins, J. R., & Luciano, J. V.
Affiliations
  • Department of Basic, Developmental and Educational Psychology, Autonomous University of Barcelona, Barcelona, Spain
  • Universitat Internacional de Catalunya (ES)
  • Parc Sanitari Sant Joan de Deu, Sant Boi de Llobregat, Catalunya, Spain
  • Department of Basic and Clinical Psychology and Psychobiology, Universitat Jaume I, Castelló de la Plana, Spain
  • Uppsala University (SE)
  • Personal Social Services Research Unit, London School of Economics and Political Science, London, UK
  • Consorci Parc de Salut MAR de Barcelona, Barcelona, Catalunya, Spain
  • Instituto de Salud Carlos III (ES)
  • Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia
  • Chulalongkorn University (TH)
  • Universitat Autònoma de Barcelona (ES)
  • Parc de Salut (ES)
  • Parc Sanitari Sant Joan de Déu (ES)
Corresponding author
Luciano, Juan V
Venue
BMJ Open
Publisher
BMJ
Published
2020-07
Volume
10
Issue
7
Pages
e038107
ISSN
2044-6055 (ISSN-L)
OpenAlex
W3045400208
Cited by
16
References
76
Citations by year
2025: 3 · 2024: 2 · 2023: 3 · 2022: 8
FWCI
1.80
Type
journal article
Language
en
Open access
Locations
  • BMJ Open (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • QUT ePrints (Queensland University of Technology) (acceptedVersion, cc-by-nc)
  • London School of Economics and Political Science Research Online (London School of Economics and Political Science) (acceptedVersion)
  • London School of Economics and Political Science Theses Online (London School of Economics and Political Science) (acceptedVersion)
  • Uppsala University Publications (Uppsala University) (acceptedVersion, other-oa)
  • Hispana (acceptedVersion, cc-by-nc)
  • HighWire Press Open Archive (acceptedVersion)
  • Repositori UJI (Universitat Jaume I) (acceptedVersion, cc-by-nc)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by-nc)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UIC Open Acces Archive (submittedVersion, cc-by-nc)
  • Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by-nc)
  • Repositorio Institucional de la Universidad de Málaga (University of Málaga) (submittedVersion, other-oa)
Funders
Instituto de Salud Carlos III (CPII19/00003, PI16/00165, PI19/00112)
Topics
  • Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
acceptance and commitment therapy, chronic low back pain, depression, pain interference, cortisol, hair cortisol, corticosteroid-binding globulin, vitamin D, immune-inflammatory markers, cost-utility analysis, mediators and moderators, treatment acceptability, psychological flexibility, impact
MeSH terms
Ecological Momentary Assessment, Depression, Humans, Spain, Technology, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Low Back Pain, Acceptance and Commitment Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy, cost-utility and physiological effects of Acceptance and Commitment Therapy (ACT) and Behavioural Activation Treatment for Depression (BATD) in patients with chronic low back pain and depression: study protocol of a randomised, controlled trial including mobile-technology-based ecological momentary assessment (IMPACT study). https://app.cochat.ai/papers/10.1136/bmjopen-2020-038107
The paper
Sanabria-Mazo, J. P., Forero, C. G., Cristobal-Narváez, P., Suso-Ribera, C., García-Palacios, A., Colomer-Carbonell, A., Pérez-Aranda, A., Andrés-Rodríguez, L., McCracken, L. M., D'Amico, F., Estivill-Rodríguez, P., Carreras-Marcos, B., Montes-Pérez, A., Comps-Vicente, O., Esteve, M., Grasa, M., Rosa, A., Cuesta-Vargas, A. I., Maes, M., . . . Luciano, J. V. (2020). Efficacy, cost-utility and physiological effects of Acceptance and Commitment Therapy (ACT) and Behavioural Activation Treatment for Depression (BATD) in patients with chronic low back pain and depression: study protocol of a randomised, controlled trial including mobile-technology-based ecological momentary assessment (IMPACT study). BMJ Open. https://doi.org/10.1136/bmjopen-2020-038107

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.